<DOC>
	<DOCNO>NCT02006368</DOCNO>
	<brief_summary>The purpose study determine life span functional characteristic platelet derive whole blood store refrigerator 21 day . Currently , platelet separate red cell shortly donation stored room temperature longer 5 day . This study consider experimental ; 1 ) keep platelet original whole blood donor unit refrigerator , 2 ) reinfusing small portion donation back study-subject-donor track many transfused platelet unit circulate study-subject-donor hour day transfusion .</brief_summary>
	<brief_title>Assessment Whole Blood Cold Stored Platelets</brief_title>
	<detailed_description>Subjects enrol evaluation platelet recovery survival . Healthy subject consent enrol study 8 subject complete recovery survival evaluation 4 , 8 , 12 , 16 , 20 day storage . The order storage interval evaluate randomize . Eight subject evaluate mid-range interval long storage period meet acceptance criteria short storage period meet acceptance criterion . For instance , 12 day storage 95 % low confidence limit recoveries NOT ≥50 % fresh survival LESS one day , 8 day storage recovery ≥50 % fresh survival least one day , evaluate 10 day storage . If 10 day storage meet acceptance criterion evaluate 9 day . If 10 day storage meet acceptance criterion evaluate 11 day . Eight subject evaluate storage interval . Subjects donate one unit whole blood . This unit maintain whole blood CPD ( Citrate Phosphate Dextrose anticoagulant ) leukoreduced separated component . These WB unit store refrigerated condition ( 4°C ) 4 20 day collection . Prior refrigeration sample unit obtain various vitro test . In vivo Measurements : At end subject 's storage period ~200 mL aliquot whole blood withdrawn unit . This aliquot centrifuge platelet extract . The platelet radiolabeled 51-Cr 111-In . On day , subject return Blood Center provide 43 mL fresh blood sample . Platelets sample harvest labeled isotope . Radiolabeling do BEST method . These aliquot sequentially infuse subject . The estimated amount isotope ≤15 μCi indium ≤20 μCi chromium infuse . The total radiation dose approximately 40 μCi total body absorb dose 0.0273 rad ( 0.273 mSv ) splenic absorb dose 3.2 rad ( 32 mSv ) . Venous sample ( 10 mls/draw ) take within 2 hour reinfusion day 1 , 2 , 3 , 5 , 7 ± 1 , 10 ± 2 . After visit , subject 's participation end exit study . Stored fresh platelet recovery survival determine comparison make subject 's fresh stored platelet recovery . In vitro Assays : The follow assay perform use 50 ml sample obtain whole blood pre post storage : - platelet count - platelet function assay ( mean platelet volume , morphology score , hypotonic shock response , extent shape change , pH , PO2 , PC02 , HC03 , glucose lactate . Platelet aggregation response standard agonist ( ADP , collagen , arachidonic acid ) also measure . - platelet activation apoptotic marker ( p-selectin antigen , annexin V , platelet microparticles ) - thrombelastograph - thrombin generation test - plasma analysis coagulation , complement , microparticles fibrinolytic potential ( thrombin-antithrombin complex ( TAT ) , plasmin-antiplasmin complex ( PAP ) , soluble cd 40l , plasminogen activator inhibitor ( PAI-1 ) , complement ( C3a , C4d , C5b-9 ) - sterility - bacterial culture submit collection result evaluate 14 day later , sooner blood store short time period . A gram stain perform isolated 4° C platelet reinfusion end storage . All sterility test must negative test platelet reinfused .</detailed_description>
	<criteria>The subject good health , take excluded medication , satisfies Blood Center 's criterion donate blood product . Criteria also include follow guideline : Meets whole blood/platelet donor suitability requirement define 21 CFR 640.3 set forth AABB ( Reference Standard 5.4.1A , 2006 ) . Past travel restriction apply study . Weight ≥50 kg ( 110 pound ) Hemoglobin/hematocrit : ≥12.5 g/dL/38 % Temperature : le equal 37.5 degree C Resting blood pressure : systolic less equal 180 mmHg ; diastolic ≥100 mmHg Resting heart rate : 50 100 beat per minute Age ≥ 18 year , either sex ; Able read , understand sign inform consent document commit study followup schedule ; Subjects must good vein whole blood collection followup blood draw ; Subjects childbearing potential must agree use effective contraceptive course study ; Those subject reinfused within 10 day 500 mL WB collection must meet criterion donate double RBC unit accommodate sampling volume occur shortly thereafter : Male subject must weigh minimum 130 lb least 5 ' 1 '' tall Female subject must weigh minimum 150 lb least 5 ' 5 '' tall Both male female subject must Hematocrit ≥ 40 % ; Any serious medical illness and/or therapy , include : abnormal bleeding episode , clot bleed disorder , evidence anemia , myocardial infarction , uncontrolled hypertension , heart disease , surgery bleeding complication , epilepsy major surgery ( general spinal anesthesia ) within last 6 month ; Taking aspirin , AlkaSeltzer™ , clopidogrel , `` antiplatelet '' drug within 7 day prior donation . Taking nonsteroidal antiinflammatory drug ( example : Motrin™ , Advil™ , ibuprofen ) within 3 day prior donation . Taking anticoagulant medication ( example Coumadin , dabigatran , rivaroxaban medication chemically related heparin ) . Currently pregnant nursing within 6 week prior enrollment assess interview . Current status confirm pregnancy test prior radioisotope infusion . Inability comply protocol opinion investigator . Participation another investigational trial would potentially interfere analysis investigation ( e.g. , pharmaceutical ) ; Have participate ≥ 4 research study involve radioisotope within last 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Volunteers</keyword>
	<keyword>Blood Platelets</keyword>
	<keyword>Platelet Transfusion</keyword>
</DOC>